Amanote Research
Register
Sign In
535 New Regional Dermatoses During Dupilumab Therapy for Atopic Dermatitis
Journal of Investigative Dermatology
- United Kingdom
doi 10.1016/j.jid.2019.03.611
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Date
May 1, 2019
Authors
G.A. Zhu
J.K. Chen
A. Chiou
J.M. Ko
G. Honari
Publisher
Elsevier BV
Related search
Dupilumab for the Treatment of Atopic Dermatitis
Prescriber
Pharmacology
Alopecia Areata After Dupilumab for Atopic Dermatitis
JAAD Case Reports
Dermatology
Dupilumab in Atopic Dermatitis: Rationale, Latest Evidence and Place in Therapy
Therapeutic Advances in Chronic Disease
Medicine
Atopic Dermatitis: New Targets of Therapy
Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child Health
Pediatrics
Perinatology
Dupilumab-Induced Phenotype Switching From Atopic Dermatitis to Psoriasis
JAAD Case Reports
Dermatology
Real‐world Use of Dupilumab for 53 Patients With Atopic Dermatitis in Japan
Journal of Cutaneous Immunology and Allergy
Proactive Therapy of Atopic Dermatitis
Klinicheskaya Dermatologiya i Venerologiya
Dermatology
Infectious Diseases
673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology